Goldman Sachs Neutral rating on Omnicare (NYSE: OCR) remains as they fill their CEO vacancy with an experienced McKesson executive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE